COVID-19 Information vaccine

WFH and EHC issue joint statement on AstraZeneca COVID-19 vaccine

The World Federation of Haemophilia (WFH) and European Haemophilia Consortium (EHC) yesterday issued a joint statement on the AstraZeneca vaccine for people with rare bleeding disorders.

The take-home message for us is:

  • The benefits of the vaccine continue to outweigh the risks for people who receive it.
  • The risks of adverse events is no higher in people with bleeding disorders.

Read the full statement here.

1 comment

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: